Program Type: ASHP accredited two-year residency (PGY1 and PGY2)
ASHP Match Number: 254347
PGY1 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
Graduates of the program will have competencies in the provision of care for research participants, the regulatory requirements that govern clinical research, and pharmacy operations required to support the evolving and complex clinical research enterprise. Participants will be expected to be a leader capable of managing the care of research participants, collaborating with the health care team to provide safe and effective care to research participants, understanding institutional operations for the conduct of research, and advancing practice for this patient population.
- Collaboration with the health care team to provide safe and effective patient care
- Understanding of the drug approval process and the implications of each component on organizational operations and role of key stakeholders
- Management of the medication –use process for drugs used in clinical trials
- Understanding of institutional, federal and state regulations that govern research
- Strategies in the prevention of medication errors and adverse events
- Develop skills in financial management and budgeting of services to support clinical trials
- Experience with the external agencies, organizations and sponsors that impact the conduct of research
- Investigational Drug Service
- Investigational Drug Service–Oncology
- Clinical Research Operations
- Human Research Protections and IRB Review
- Drug Development–Clinical Pharmacology (2)
- Clinical Care with Research Patients (ex: Hematologic Malignancies or Pediatric Oncology)
- Investigational Drug Service Leadership
- Oncology Medication Use Safety (Longitudinal)
- Oncology Clinical Decision Support
- NIH: National Cancer Institute, Pharmaceutical Management Branch
- On- Demand Pharmaceuticals
- All applications will be accepted through PhORCAS.
- Pre-requisites for the Investigational Drugs and Research PGY1/PGY2 program:
- Doctor of Pharmacy degree from an ACPE accredited school or college.
- Minimum 3.0 GPA on a 4.0 scale.
- Link to the application information: http://www.hopkinsmedicine.org/pharmacy/residents/application/
Special Requirements for Application
Eligibility for licensure in Maryland. Application material should include a curriculum vitae documenting: (a) education, (b) work experience, (c) rotations, (d) community service, (e) association involvement, (f) leadership, (g) awards/honors, (h) presentations and publications, (i) letter of intent, (j) three references and your (k) College of Pharmacy transcript. Participation in the ASHP Matching program as a PGY-1 candidate. Participation in Personnel Placement Service at the Midyear Clinical Meeting is recommended.
Janet Mighty, B.S. Pharm, M.B.A.
Director, Investigational Drug Service
B.S. Pharmacy, University of Maryland
Masters in Business Administration, Loyola College, Baltimore, MD
Location: The Johns Hopkins Hospital
600 North Wolfe St./Carnegie 180
Baltimore, MD 21287-6180
Phone (Office): 410-955-6337
Email: [email protected]